CSF3 and ulcer disease: used recombinant human granulocyte colony-stimulating factor (G-CSF) 5–10 μg/kg/day for the proliferation of BM-MSCs in DFU patients for 4–5 consecutive days to promote their release into peripheral blood and then took peripheral blood MSCs and injected them around or at the bottom of ulcers.